SCHEDULE 13G

Statement of Beneficial Ownership

4D Molecular Therapeutics, Inc. Filed 2026-11-10 Acc 0000093751-26-000602

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-11-12 10-Q Quarterly Report
2026-11-12 8-K Results of operations
2026-11-10 SCHEDULE 13G Statement of Beneficial Ownership
2026-05-12 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)